About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNPhase 3NCT01447940

Prospective Assessment of Meos Telemedicine E-portal on Ambulatory Care of Type 1 Diabetic Patients

Primary objective of TELEDIAB-3 study is to demonstrate that the use of Meos Telemedicine ePortal for sharing information between diabetologist and type 1 diabetic patient is not inferior to a convent...

Lead sponsor: University Hospital, Grenoble•8 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Hospital, Grenoble

Meos is the name of the website (Telemedicine ePortal) tested in this trial ; it is used to share informations between diabetologist and type 1 diabetic patients.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patient with type 1 diabetes mellitus for ≥ 12 months or more
•Age \> 18 years old
•Patient who is followed since 6 month into investigator hospital
•Patient with available internet access at least once a week, and ability to understand MEOS website navigation
•Patient using a compatible glucose meter (One touch ultra, Optium xceed, or BG star)

Exclusion Criteria

•Patient with no easy and regular access to the Internet;
•Patient found to be unfit for use of the telematic tools or e-mail tools
•Patient with toxicomania, alcoholism or psychological troubles
•Type 2 diabetic patients
•Patient who does not need strict metabolic objectives
•Pregnant or parturient women
•Person with no freedom (prisoner)

Related studies

RECRUITINGPhase 3

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

NCT07222137 · Diabetes Mellitus, Type 1

General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

NCT06807190 · Diabetes Mellitus, Type 1

A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar

NCT07160816 · Diabetes Mellitus, Type 1

RECRUITINGPhase 3

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

NCT04786262 · Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, and more

Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery

NCT07478211 · Diabetes Mellitus, Type 1, Energy Metabolism

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 9, 2014Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE3

Enrollment720

Start dateJan 2012

Last updatedDec 9, 2014

Condition

Diabetes Mellitus, Type 1

Locations shown

University Hospital, Department of Endocrinology

Grenoble, Auvergne-Rhône-Alpes

University Hospital of Caen (Hospital Côte de nacre)

Caen, Basse-Normandie

University Hospital of Besancon - Hospital Jean Minjoz

Besançon, Franche Comté

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 9, 2014Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions